Certified by Founder Lodge
Royalty Pharma
United States - New York, New York
INVESTOR
1 Disclosed Funding Rounds $50,000,000
1 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators fro
K Health
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
XCENA | $135,000,000 | (Jun 2, 2026)
Human Archive (YC W26) | $8,200,000 | (Jun 2, 2026)
Invertix | $1,977,831 | (Jun 2, 2026)
Gray Swan | $40,000,000 | (Jun 2, 2026)
Solstice | $21,000,000 | (May 29, 2026)
